Drug Trial Radar · NCT04252742
Erenumab - Comprehensive Assessment of Efficacy in (High-Frequency) Episodic Migraine
Last checked: Nov 20, 2026Latest source record: Mar 31, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
512
Actual
Start
Sep 15, 2020
Primary completion
Oct 26, 2023
Study completion Oct 26, 2023
Sponsor
- Lead sponsor
- AmgenAmgen (AMGN)
- Sponsor type
- Industry
- First posted
- Feb 5, 2020
Design
- Study type
- Interventional
- Phase
- Phase 4
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Double (participant, investigator)
- Primary purpose
- Prevention
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The primary objective of this study is to evaluate the treatment benefit of erenumab on headache duration of at least moderate pain intensity.
Conditions
- Migraine
Interventions
ErenumabDrug
140 mg, 2 consecutive injections of 70 mg
PlaceboDrug
2 consecutive injections
Primary outcomes
What the sponsor says the trial is designed to measure.
- Change From Baseline in Mean Monthly Hours of at Least Moderate Headache Pain Intensity Over Months 1, 2, and 3Time frame: Baseline, Month 1, Month 2, and Month 3
Locations
91 sites in 9 countries. Site status is shown where the registry gives one.
Long Beach Clinical Trials Services Inc
Long Beach, California
Clinical Research Institute, LLC
Los Angeles, California
Mountain Neurological Research Center
Basalt, Colorado
Denver Neurological Clinic
Denver, Colorado
Summit Headache and Neurologic Institute
Englewood, Colorado
JEM Research Institute
Atlantis, Florida
Jacksonville Center for Clinical Research
Jacksonville, Florida
Visionary Investigators Network
Miami, Florida
Renstar Medical Research
Ocala, Florida
Heuer Medical Doctor Research LLC
Orlando, Florida
Neurology Associates of Ormond Beach
Ormond Beach, Florida
Visionary Investigators Network
Pembroke Pines, Florida
Saint Lukes Clinic
Meridian, Idaho
Chicago Headache Center and Research Institute
Chicago, Illinois
Boston Clinical Trials
Boston, Massachusetts
New England Regional Headache Center Inc
Worcester, Massachusetts
Michigan Head Pain and Neurological Institute
Ann Arbor, Michigan
StudyMetrix Research
City of Saint Peters, Missouri
Clinvest Research LLC
Springfield, Missouri
Mercy Health Research
St Louis, Missouri
Papillion Research Center
Papillion, Nebraska
Forte Family Practice
Las Vegas, Nevada
Dent Neurosciences Research Center
Amherst, New York
American Clinical Research Institute LLC
Beavercreek, Ohio
University of Cincinnati
Cincinnati, Ohio
Cleveland Clinic
Cleveland, Ohio
Summit Research Network
Portland, Oregon
Palmetto Clinical Trial Services
Greenville, South Carolina
Nashville Neuroscience Group
Nashville, Tennessee
FutureSearch Trials of Neurology
Austin, Texas
North Texas Institute of Neurology and Headache
Frisco, Texas
University Multiprofile Hospital for Active Treatment - Dr Georgi Stranski EAD
Pleven, Bulgaria
University Multiprofile Hospital for Active Treatment Sveti Georgi EAD
Plovdiv, Bulgaria
Multiprofile Hospital for Active Treatment in neurology and psychiatry Sveti Naum EAD
Sofia, Bulgaria
University First Multiprofile Hospital for Active Treatment - Sofia Sveti Yoan Krastitel EAD
Sofia, Bulgaria
Medical Center Excelsior OOD
Sofia, Bulgaria
University Multiprofile Hospital for Active Treatment Alexandrovska EAD
Sofia, Bulgaria
Medical Center New Rehabilitation Center EOOD
Stara Zagora, Bulgaria
Neurologie Brno sro
Brno, Czechia
Fakultni nemocnice u svate Anny v Brne
Brno, Czechia
Showing 40 of 91 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.